Austin Health

Title
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Publication Date
2023
Author(s)
Spelman, Tim
Ozakbas, Serkan
Alroughani, Raed
Terzi, Murat
Hodgkinson, Suzanne
Laureys, Guy
Kalincik, Tomas
Van Der Walt, Anneke
Yamout, Bassem
Lechner-Scott, Jeannette
Soysal, Aysun
Kuhle, Jens
Sanchez-Menoyo, Jose Luis
Blanco Morgado, Yolanda
Spitaleri, Daniele LA
van Pesch, Vincent
Horakova, Dana
Ampapa, Radek
Patti, Francesco
Macdonell, Richard A L
Al-Asmi, Abdullah
Gerlach, Oliver
Oh, Jiwon
Altintas, Ayse
Tundia, Namita
Wong, Schiffon L
Butzkueven, Helmut
Subject
MS
disability
discontinuation
real-world data
registry
relapse
switching
Type of document
Journal Article
OrcId
0000-0001-9204-3216
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0001-5436-5804
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0003-3778-1376
0000-0002-4278-7003
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-3850-447X
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0003-1915-0036
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0002-6923-0846
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
0000-0001-5519-6088
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
#PLACEHOLDER_PARENT_METADATA_VALUE#
DOI
10.1177/13524585221137502
Abstract
Effectiveness of cladribine tablets, an oral disease-modifying treatment (DMT) for multiple sclerosis (MS), was established in clinical trials and confirmed with real-world experience.
Link
link
Citation
Multiple Sclerosis Journal 2023
Jornal Title
Multiple Sclerosis Journal
ISSN
1477-0970

Files:

NameSizeformatDescriptionLink